1. Home
  2. TARA vs FEAM Comparison

TARA vs FEAM Comparison

Compare TARA & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARA
  • FEAM
  • Stock Information
  • Founded
  • TARA N/A
  • FEAM 2016
  • Country
  • TARA United States
  • FEAM United States
  • Employees
  • TARA N/A
  • FEAM N/A
  • Industry
  • TARA Biotechnology: Biological Products (No Diagnostic Substances)
  • FEAM Major Chemicals
  • Sector
  • TARA Health Care
  • FEAM Industrials
  • Exchange
  • TARA Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • TARA 118.1M
  • FEAM 94.7M
  • IPO Year
  • TARA N/A
  • FEAM N/A
  • Fundamental
  • Price
  • TARA $3.03
  • FEAM $3.99
  • Analyst Decision
  • TARA Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • TARA 6
  • FEAM 2
  • Target Price
  • TARA $19.80
  • FEAM $9.75
  • AVG Volume (30 Days)
  • TARA 148.6K
  • FEAM 132.7K
  • Earning Date
  • TARA 11-11-2025
  • FEAM 11-12-2025
  • Dividend Yield
  • TARA N/A
  • FEAM N/A
  • EPS Growth
  • TARA N/A
  • FEAM N/A
  • EPS
  • TARA N/A
  • FEAM N/A
  • Revenue
  • TARA N/A
  • FEAM N/A
  • Revenue This Year
  • TARA N/A
  • FEAM N/A
  • Revenue Next Year
  • TARA N/A
  • FEAM N/A
  • P/E Ratio
  • TARA N/A
  • FEAM N/A
  • Revenue Growth
  • TARA N/A
  • FEAM N/A
  • 52 Week Low
  • TARA $1.60
  • FEAM $2.82
  • 52 Week High
  • TARA $10.48
  • FEAM $24.84
  • Technical
  • Relative Strength Index (RSI)
  • TARA 43.85
  • FEAM 52.42
  • Support Level
  • TARA $3.05
  • FEAM $3.72
  • Resistance Level
  • TARA $3.20
  • FEAM $4.50
  • Average True Range (ATR)
  • TARA 0.13
  • FEAM 0.31
  • MACD
  • TARA -0.01
  • FEAM 0.04
  • Stochastic Oscillator
  • TARA 3.33
  • FEAM 57.50

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: